Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

NCT04966741 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Bardet-Biedl Syndrome
POMC Deficiency Obesity
PCSK1 Deficiency Obesity
LEPR Deficiency Obesity

Interventions

DRUG: Setmelanotide

Sponsor

Rhythm Pharmaceuticals, Inc.